From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH
Reda Mansour,
No information about this author
Sherif S Abdel Mageed,
No information about this author
Ahmed I. Abulsoud
No information about this author
et al.
Functional & Integrative Genomics,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Jan. 31, 2025
Language: Английский
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
Meysam Ramezani,
No information about this author
Mahsa Zobeiry,
No information about this author
Shahrokh Abdolahi
No information about this author
et al.
Pathology - Research and Practice,
Journal Year:
2023,
Volume and Issue:
251, P. 154809 - 154809
Published: Sept. 16, 2023
Language: Английский
MicroRNAs in the Diagnosis of Digestive Diseases: A Comprehensive Review
Mirela Livia Popa,
No information about this author
Cristian Ichim,
No information about this author
Paula Anderco
No information about this author
et al.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(6), P. 2054 - 2054
Published: March 18, 2025
MicroRNAs
(miRNAs)
have
emerged
as
crucial
regulators
in
digestive
pathologies,
including
inflammatory
bowel
disease
(miR-31,
miR-155,
and
miR-21),
colorectal
cancer
(miR-21,
miR-598,
miR-494),
non-alcoholic
fatty
liver
miR-192,
miR-122).
Their
capacity
to
modulate
gene
expression
at
the
post-transcriptional
level
makes
them
highly
promising
candidates
for
biomarkers
therapeutic
interventions.
However,
despite
considerable
progress,
their
clinical
application
remains
challenging.
Research
has
shown
that
miRNA
is
dynamic,
varying
across
patients,
stages,
different
intestinal
regions.
dual
function
both
oncogenes
tumor
suppressors
further
complicates
use,
targeting
miRNAs
may
yield
unpredictable
effects.
Additionally,
while
miRNA-based
therapies
hold
great
potential,
significant
hurdles
persist,
off-target
effects,
immune
activation,
inefficiencies
delivery
methods.
The
intricate
interplay
between
gut
microbiota
adds
another
layer
of
complexity,
influencing
mechanisms
treatment
responses.
This
review
examined
role
emphasizing
diagnostic
potential.
While
they
offer
new
avenues
management,
unresolved
challenges
underscore
need
research
refine
application.
Language: Английский
Deciphering the molecular mediators of triclosan-induced lipid accumulation: Intervention via short-chain fatty acids and miR-101a
Jin Yan,
No information about this author
Jinyun Li,
No information about this author
Yang Wang
No information about this author
et al.
Environmental Pollution,
Journal Year:
2023,
Volume and Issue:
343, P. 123153 - 123153
Published: Dec. 14, 2023
Language: Английский
The Molecular Mechanism of circRNA-11228/miR-103/INSIG1 Pathway Regulating Milk Fat Synthesis in Bovine Mammary Epithelial Cells
Agriculture,
Journal Year:
2024,
Volume and Issue:
14(4), P. 538 - 538
Published: March 28, 2024
Milk,
known
for
its
high
content
of
short-
and
medium-chain
fatty
acids
unsaturated
acids,
has
attracted
substantial
attention
due
to
nutritional
health
value.
The
regulation
acid
metabolism
by
non-coding
RNAs
become
a
subject
growing
attention,
particularly
in
relation
production
at
the
transcriptional/epigenetic
post-transcriptional
levels.
This
study
established
circRNA-11228/miR-103/INSIG1
(insulin-inducible
gene)
regulatory
network
using
methods
such
as
qRT-PCR,
dual
luciferase
reporting,
Western
blot,
with
INSIG1
serving
starting
point.
experimental
validation
circRNA-11228’s
impact
on
cholesterol
levels,
lipid
droplet
secretion,
was
conducted
various
assays,
including
triglycerides,
cholesterol,
oil
red
O,
andEdU(5-ethynyl-2’-deoxyuridine)
bovine
mammary
epithelial
cells
(BMECs).
Furthermore,
transfection
mimics
inhibitors
synthesized
from
miR-103
into
BMECs
confirmed
that
can
promote
synthesis
secretion.
Conversely,
gene
found
inhibit
“remediation”
experiment
validated
ability
alleviate
cellular
effect
circRNA-11228.
Taken
together,
our
findings
indicate
binding
circRNA-11228
inhibits
expression
target
INSIG,
thereby
regulating
milk
fat
BMECs.
offers
novel
insights
producing
high-quality
new
ways
improve
dietary
composition
residents.
Language: Английский
Lipid Regulatory Element Interact with CD44 on Mitochondrial Bioenergetics in Bovine Adipocyte Differentiation and Lipometabolism
Guanghui Li,
No information about this author
Xibi Fang,
No information about this author
Yinuo Liu
No information about this author
et al.
Journal of Agricultural and Food Chemistry,
Journal Year:
2024,
Volume and Issue:
72(31), P. 17481 - 17498
Published: July 29, 2024
The
CD44
gene
is
a
critical
factor
in
animal
physiological
processes
and
has
been
shown
to
affect
insulin
resistance
fat
accumulation
mammals.
Nevertheless,
little
research
conducted
on
its
precise
functions
lipid
metabolism
adipogenic
differentiation
beef
cattle.
This
study
analyzed
the
expression
of
miR-199a-3p
during
bovine
preadipocyte
differentiation.
luciferase
reporter
assay
demonstrated
that
was
direct
target
miR-199a-3p.
Increased
droplets
triglyceride
levels,
altered
fatty
acid
metabolism,
accelerated
were
all
caused
by
upregulation
or
reduction
expression.
knockdown
upregulated
adipocyte-specific
genes
(LPL
FABP4)
levels
metabolites
(SOPC,
l-arginine,
heptadecanoic
acid).
Multiomics
highlights
enriched
pathways
involved
energy
(MAPK,
cAMP,
calcium
signaling)
shifts
mitochondrial
respiration
glycolysis,
indicating
plays
regulatory
role
metabolism.
findings
show
intracellular
lipolysis,
respiration,
deposition,
droplet
composition
are
impacted
miR-199a-3p,
which
modulates
adipocytes.
Language: Английский
Differential Hepatic Expression of miRNA in Response to Aflatoxin B1 Challenge in Domestic and Wild Turkeys
Kade Jorud,
No information about this author
Kristelle M. Mendoza,
No information about this author
Thomas J. Y. Kono
No information about this author
et al.
Toxins,
Journal Year:
2024,
Volume and Issue:
16(11), P. 453 - 453
Published: Oct. 22, 2024
Aflatoxin
B1
(AFB
Language: Английский
Unveiling Mir-101a as a Molecular Mediator in Triclosan-Induced Lipid Metabolism Disruption: Implications for Obesity and Metabolic Dysfunction
Jin Yan,
No information about this author
Jinyun Li,
No information about this author
Yang Wang
No information about this author
et al.
Published: Jan. 1, 2023
As
a
potential
environmental
obesogen,
triclosan
(TCS)
carries
inherent
risks
of
inducing
obesity
and
metabolic
disorders.
However,
the
underlying
molecular
mechanisms
behind
lipid
metabolism
disorder
induced
by
TCS
have
remained
elusive.
Through
fusion
transcriptomics
microRNA
target
prediction,
our
investigation
supposes
that
miR-101a
as
responsive
miRNA
to
exposure
in
zebrafish,
playing
central
role
disturbing
homeostasis.
evidence
triggers
reduction
expression,
accompanied
elevation
genes
linked
precision-controlled
interventions
involving
expression
modulation,
we
discovered
inhibition
heightened
its
implicated
homeostasis,
subsequently
triggering
excessive
fat
accumulation.
Meanwhile,
overexpression
acts
protective
mechanism,
counteracting
larvae.
Notably,
combination
short-chain
fatty
acids
(SCFAs)
emerged
remedy
alleviate
TCS-induced
accumulation
partially
decline
TCS.
These
revelations
provide
insight
into
prospective
framework
TCS-triggered
disorders,
thereby
paving
way
for
pre-emptive
strategies
combating
ramifications
pollution.
Language: Английский